They tried the microbiome - the accumulation of infinitesimal species that live in us - in growth patients.
Two examinations, in the diary Science, connected particular species and the general assorted variety of the microbiome to the viability of immunotherapy drugs.
Specialists said the outcomes were interesting and held a great deal of guarantee.
Our bodies are home to trillions of miniaturized scale living beings and the connection amongst "us" and "them" goes a long ways past irresistible illnesses.
The microbiome is associated with absorption, assurance from contamination and managing the resistant framework.
Gut bugs 'help keep sensitivities'
Parkinson's ailment 'may begin in gut'
The two examinations were on patients accepting immunotherapy, which supports the body's own safeguards to battle tumors.
It doesn't work in each patient, however sometimes it can clear even terminal growth.
Survival
One investigation, at the Gustave Roussy Disease Grounds in Paris, took a gander at 249 patients with lung or kidney growth.
They demonstrated the individuals who had taken anti-microbials, for example, for dental disease, harmed their microbiome and will probably observe tumors develop while on immunotherapy.
One types of microbes specifically, Akkermansia muciniphila, was in 69% of patients that responded contrasted and only 33% of the individuals who did not.
Boosting levels of A. muciniphila in mice appeared to likewise support their reaction to immunotherapy.
In the mean time, at the College of Texas MD Anderson Growth Center, 112 patients with cutting edge melanoma had their microbiome broke down.
Those that reacted to treatment had a tendency to have a wealthier, more different microbiome than those that did not.
What's more, they had distinctive microorganisms as well. Elevated amounts of Faecalibacterium and Clostridiales had all the earmarks of being advantageous, while Bacteroidales species were awful news in the examination.
'Amusement evolving'
Tissues tests appeared there were more growth slaughtering safe cells in the tumor of individuals with the valuable microscopic organisms.
The group at that point played out a trans-crap sion, a transplant of fecal issue, from individuals to mice with melanoma.
Mice given microbes from patients with the "great" blend of microscopic organisms had slower-developing tumors than mice given "terrible" microorganisms.
Dr Jennifer Wargo, from Texas, told the BBC: "In the event that you upset a patient's microbiome you may impede their capacity to react to disease treatment."
She is arranging clinical trials went for adjusting the microbiome pair with disease treatment.
She stated: "Our theory is whether we change to a more great microbiome, you just might have the capacity to improve patients react.
"The microbiome is diversion changing, not simply growth but rather for general wellbeing, it's certainly going to be a noteworthy player."
Promising
Stamp Defender, leader of the General public for Connected Microbiology and educator of restorative science at Kingston College, said the examination demonstrated the significance of understanding the miniaturized scale life forms that call our bodies home.
He told the BBC: "It's truly fascinating and holds a considerable measure of guarantee, we have to accomplish more work yet there are energizing flashes here in treating some troublesome ailments.
"Some claim the microbiome is the response to everything, I don't surmise that is the situation.
"In any case, once we see more, it may be the case that microbiome control is essential in changing individuals' wellbeing."
Dr Emma Smith from Malignancy Exploration UK, stated: "It's intriguing.
"One of the enormous difficulties for utilizing immunotherapies to treat disease is understanding which patients will react, and this exploration is a stage towards helping specialists to recognize these individuals."
